Efficacy and toxicity of dexamethasone vs methylprednisolone-long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002.

A.I. Karachunskiy,Julia Roumiantseva,Svetlana Lagoiko,Bührer C,Gesche Tallen,Olga Aleinikova,O.I. Bydanov,Natalia Korepanova,L Bajdun,Tatyana V. Nasedkina,A von Stackelberg,Galina Novichkova,Alexey A. Maschan,D.V. Litvinov,Natalia Myakova,N. I. Ponomareva,Konstantin Kondratchik,Larisa Fechina,Olga Streneva,N Judina,G Scharapova,Shamardina Av,Gerbek Ie,Shapochnik Ap,A Rumjanzew,Günter Henze

Efficacy and toxicity of dexamethasone vs methylprednisolone-long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002.

2015

Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002

Keywords:

Cancer research
Oncology
Dexamethasone
Pediatrics
Methylprednisolone
Internal medicine
Medicine
Toxicity
Precursor Cell Lymphoblastic Leukemia Lymphoma
long term results

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations